| 10-Jun-13 04:25PM | Update on Gentium's Defibrotide Zacks |
| 04-Jun-13 06:01AM | InPlay: Gentium files documentation requesting a Re-examination of the negative opinion given by the EMA's CHMP regarding the MAA for Defibrotide to treat and prevent hepatic veno-occlusive disease in adults and children undergoing hematopo Briefing.com |
| 06:00AM | Gentium Provides Update on Re-Examination of Defibrotide MAA to EMA GlobeNewswire |
| 31-May-13 04:30PM | BMRN's Vimizim Under Review Zacks |
| 29-May-13 10:07AM | Gentium SpA Stock Upgraded (GENT) at TheStreet |
| 14-May-13 07:07AM | Q1 2013 Gentium SpA Earnings Release - 07:00 am ET CCBN |
| 07:00AM | Gentium Reports First Quarter Financial Results GlobeNewswire |
| 09-May-13 05:10AM | Why Are These 3 European Stocks Attracting Institutional Buyers? at Seeking Alpha |
| 23-Apr-13 05:10PM | Is The Bad News Already Priced In For These 5 Short Squeeze Picks? at Seeking Alpha |
| 18-Apr-13 04:27PM | Oversold Conditions For Gentium SpA (GENT) at TheStreet |
| 16-Apr-13 03:57PM | 4 Healthcare Stock Stories For Tuesday Investment Wellness at Wall St. Cheat Sheet |
| 06:30AM | InPlay: Gentium to request re-examination of CHMP opinion on Defibrotide Briefing.com |
| 06:30AM | Gentium to Request Re-Examination of CHMP Opinion on Defibrotide GlobeNewswire |
| 09-Apr-13 04:30PM | Satellite Symposia on Defibrotide and Veno-Occlusive Disease at EBMT 39th Annual Meeting GlobeNewswire |
| 05-Apr-13 01:04PM | GENTIUM S.P.A. Financials EDGAR Online Financials |
| 28-Mar-13 09:00PM | Gentium Announces Resignation of Board Member GlobeNewswire |
| 07:23AM | Gentium Reports Fourth Quarter and Year End 2012 Financial Results GlobeNewswire |
| 07:07AM | Q4 and Year-End 2012 GENTIUM SPA Earnings Release - Time Not Supplied CCBN |
| 27-Mar-13 05:45PM | Gentium S.p.A Earnings: What Investors Should Watch at Wall St. Cheat Sheet |
| 26-Mar-13 09:18AM | CHMP Negative on Gentium Candidate Zacks |
| 08:35AM | Gentium Announces Initiation of Phase 1 study in Japan GlobeNewswire |
| 22-Mar-13 02:36PM | 4 Healthcare Stock Stories for Weekend Wellness at Wall St. Cheat Sheet |
| 08:34AM | InPlay: Gentium receives negative opinion from the CHMP on Defibrotide for the treatment and prevention of VOD Briefing.com |
| 08:33AM | Gentium receives negative opinion from CHMP on Defibrotide for treatment of VOD theflyonthewall.com |
| 08:30AM | Gentium Receives Negative Opinion From the CHMP on Defibrotide for the Treatment and Prevention of VOD GlobeNewswire |
| 07:46AM | Gentium shares halted, news pending theflyonthewall.com |
| 21-Mar-13 07:00AM | Gentium to Report Fourth Quarter and Full Year 2012 Financial Results GlobeNewswire |
| 21-Feb-13 08:04AM | UPDATE 2-Italy's Gentium plummets as EU says "no" to key drug at Reuters -20.62% |
| 07:54AM | BRIEF-Gentium slumps 41 percent in premarket trading at Reuters |
| 07:39AM | Gentium provides update on Defibrotide marketing authorization at theflyonthewall.com |
| 07:30AM | UPDATE 1-Italy's Gentium fails to wins EU backing for key drug at Reuters |
| 07:01AM | InPlay: Gentium provides update on the review of Defibrotide Marketing Authorization; co expects an opinion recommending against approval of the Marketing Authorization Application for Defibrotide Briefing.com |
| 07:00AM | Gentium Provides Update on the Review of Defibrotide Marketing Authorization GlobeNewswire |
| 12-Feb-13 03:53AM | Promising Italian Biotech With An Upcoming CHMP Meeting at Seeking Alpha |
| 17-Jan-13 09:29AM | 7:03 am Gentium Provides an Update on Defibrotide MAA to EMA; MAA will be on the agenda for discussion at the EMA CHMP meetings scheduled to be held on February 18-21, 2013 Briefing.com |
| 09:09AM | 7:03 am Gentium Provides an Update on Defibrotide MAA to EMA; MAA will be on the agenda for discussion at the EMA CHMP meetings scheduled to be held on February 18-21, 2013 Briefing.com |
| 08:35AM | 7:03 am Gentium Provides an Update on Defibrotide MAA to EMA; MAA will be on the agenda for discussion at the EMA CHMP meetings scheduled to be held on February 18-21, 2013 Briefing.com |
| 07:57AM | 7:03 am Gentium Provides an Update on Defibrotide MAA to EMA; MAA will be on the agenda for discussion at the EMA CHMP meetings scheduled to be held on February 18-21, 2013 Briefing.com |
| 07:15AM | 7:03 am Gentium Provides an Update on Defibrotide MAA to EMA; MAA will be on the agenda for discussion at the EMA CHMP meetings scheduled to be held on February 18-21, 2013 Briefing.com |
| 07:03AM | InPlay: Gentium Provides an Update on Defibrotide MAA to EMA; MAA will be on the agenda for discussion at the EMA CHMP meetings scheduled to be held on February 18-21, 2013 Briefing.com |
| 07:00AM | Gentium Provides an Update on Defibrotide MAA to EMA GlobeNewswire |
| 18-Dec-12 07:00AM | Gentium Submit 2nd LoOIs Response to the EMA's CHMP for Defibrotide MAA GlobeNewswire -6.11% |
| 13-Dec-12 07:01AM | InPlay: Gentium reports results from its treatment IND for Defibrotide Presented at the American Society of Hematology Annual Meeting; In the subgroup of HSCT patients with sVOD, 26% achieved a CR and 45% survived to day 100 Briefing.com |
| 07:00AM | Results From Gentium's Treatment IND for Defibrotide Presented at the American Society of Hematology Annual Meeting GlobeNewswire |
| 07-Dec-12 07:00AM | Data From Non HSCT VOD Patients Treated With Defibrotide and a Treatment IND Update to be Presented at the American Society of Hematology Annual Meeting GlobeNewswire |
| 05-Dec-12 07:00AM | Gentium To Initiate Clinical Development in Japan and Expand Named-Patient Program Access to Asia and Japan GlobeNewswire |
| 19-Nov-12 04:08AM | Gentium SpA Stock Downgraded (GENT) at TheStreet |
| 15-Nov-12 07:00AM | Gentium Reports Third Quarter 2012 Financial Results GlobeNewswire |
| 10-Oct-12 07:31AM | InPlay: Gentium receives second list of outstanding issues from the EMA's CHMP for Defibrotide MAA Briefing.com |
| 07:30AM | Gentium Receives Second List of Outstanding Issues From the EMA's CHMP for Defibrotide MAA GlobeNewswire |
| 04-Oct-12 07:30AM | Gentium Appoints Biologix FZCo as Exclusive Distributor of Defibrotide in the Middle East and North Africa GlobeNewswire |
| 26-Sep-12 07:30AM | Gentium Provides Update on the Review of Defibrotide Marketing Authorization Application GlobeNewswire -7.34% |
| 17-Sep-12 05:09AM | Gentium SpA Stock Upgraded (GENT) at TheStreet |
| 13-Sep-12 07:07AM | Q2 2012 Gentium SpA Earnings Release - Time Not Supplied CCBN |
| 07:00AM | Gentium Reports First Half 2012 Financial Results GlobeNewswire |
| 11-Sep-12 07:30AM | Gentium to Present Oral Explanations to EMA's CHMP for Defibrotide MAA GlobeNewswire |
| 10-Sep-12 07:30AM | Gentium to Review First Half 2012 Financial Results GlobeNewswire |
| 28-Aug-12 09:45AM | 5 Pharmaceutical Companies With EMA Or MHRA Catalysts This Year at Seeking Alpha |
| 19-Aug-12 10:56AM | 3 Healthcare Stocks With Strong EPS Growth Projections And Analyst Rating Of Strong Buy at Seeking Alpha |
| 21-Jun-12 07:31AM | InPlay: Gentium submits day 180 response to list of outstanding issues received from the EMA's CHMP for Defibrotide MAA Briefing.com |
| 07:30AM | Gentium Submits Day 180 Response to List of Outstanding Issues Received From the EMA's CHMP for Defibrotide MAA GlobeNewswire |
| 19-Jun-12 08:21PM | Genting Likes the Echo Effect at The Wall Street Journal |
| 07-Jun-12 05:00AM | Gentium SpA Stock Downgraded (GENT) at TheStreet |
| 17-May-12 08:56AM | Gentium Reports First Quarter Financial Results GlobeNewswire |
| 04-May-12 07:31AM | InPlay: Gentium receives Day 180 list of outstanding issues from the CHMP for Defibrotide Marketing Authorization Application Briefing.com |
| 07:30AM | Gentium Receives Day 180 List of Outstanding Issues From the CHMP for Defibrotide MAA GlobeNewswire |
| 02-May-12 07:30AM | Gentium Appoints PharmaSwiss, S.A. as Exclusive Distributor of Defibrotide in Central and Eastern European Countries GlobeNewswire |
| 01-May-12 11:47AM | Interview With The President And CEO: Apricus Biosciences, Inc. (APRI) - Bassam Damaj Wall Street Transcript |
| 04-Apr-12 01:04PM | GENTIUM S.P.A. Financials EDGAR Online Financials |
| 02-Apr-12 07:36AM | Gentium Hosts Symposium on Defibrotide at EBMT Annual Meeting GlobeNewswire |
| 29-Mar-12 05:00AM | Gentium SpA Stock Upgraded (GENT) at TheStreet |
| 27-Mar-12 07:07AM | Q4 2011 & Full Year 2011 Gentium SpA Earnings Release - Time Not Supplied CCBN |
| 07:00AM | Gentium Reports Fourth Quarter and Year End 2011 Financial Results GlobeNewswire |
| 20-Mar-12 07:30AM | Gentium to Review Fourth Quarter and Year End 2011 Financial Results GlobeNewswire |
| 06-Mar-12 07:30AM | Gentium Appoints Dr. Carin Heringa as Senior Vice President and Scientific Director GlobeNewswire |
| 27-Feb-12 07:30AM | The Lancet Publishes Results from Gentium's Phase III Defibrotide Trial for the Prevention of VOD in Paediatric Patients GlobeNewswire +5.99% |
| 21-Feb-12 07:35AM | InPlay: Gentium responds to the EMA's Day 120 List of Questions for Defibrotide MAA; says ' we have finalized and submitted written responses to the LoQs' Briefing.com |
| 07:30AM | Gentium Responds to the EMA's Day 120 List of Questions for Defibrotide MAA GlobeNewswire |
| 09-Jan-12 07:30AM | Gentium Appoints Swedish Orphan Biovitrum AB as Exclusive Distributor of Defibrotide in Nordic and Baltic Territories GlobeNewswire |
| 29-Dec-11 07:32AM | InPlay: Gentium provided an update on the European Marketing Authorization Application for Defibrotide; says 'anticipates submitting a response to the Day 120 List of Questions' Briefing.com |
| 07:30AM | Gentium Provides Update on MAA Process for Defibrotide in Europe GlobeNewswire |
| 12-Dec-11 04:16PM | InPlay: Gentium announced that an oral presentation on Defibrotide was presented today at the 53nd Annual Meeting and Exposition of the American Society of Hematology held at the San Diego Convention Center in California Briefing.com |
| 04:15PM | Results From Gentium's Treatment IND for Defibrotide Presented at the American Society of Hematology Annual Meeting GlobeNewswire |
| 08-Dec-11 04:15PM | Gentium Announces Changes to Board of Directors GlobeNewswire |
| 29-Nov-11 07:30AM | Updated Results From Gentium's Treatment IND for Defibrotide to be Presented at the American Society of Hematology GlobeNewswire |
| 22-Nov-11 07:30AM | Gentium Announces Establishment of Commercial Infrastructure and Appointment of Commercial Leadership Team GlobeNewswire |
| 15-Nov-11 07:30AM | Gentium Reports Third Quarter 2011 Financial Results GlobeNewswire |
| 20-Oct-11 07:36AM | Gentium provides update on MAA process for defibrotide in Europe at theflyonthewall.com |
| 07:34AM | InPlay: Gentium provides update on MAA for Defibrotide Briefing.com |
| 07:30AM | Gentium Provides Update on MAA Process for Defibrotide in Europe GlobeNewswire |
| 04-Oct-11 07:30AM | Gentium Announces Management Change GlobeNewswire |
| 20-Sep-11 07:07AM | 1H 2011 Gentium SpA Earnings Release - Time Not Supplied CCBN |
| 07:00AM | Gentium Reports First Half 2011 Financial Results GlobeNewswire |
| 14-Sep-11 07:30AM | Gentium to Review First Half 2011 Financial Results GlobeNewswire |
| 18-Aug-11 05:23PM | [$$] Stocks in the Spotlight Thursday at Barrons.com -22.07% |
| 12:34PM | Gentium tumbles 29% on drug setback, downgrade at MarketWatch |
| 10:09AM | Gentium shares tumble after co withdraws liver drug application at Reuters |
| 08:39AM | Gentium downgraded at ThinkEquity theflyonthewall.com |
| 08:39AM | Gentium downgraded at ThinkEquity at theflyonthewall.com |
| 17-Aug-11 05:56PM | After Hours: JDSU, NetApp shares hit hard in after-hours trade at MarketWatch |
